Tool Identifies Newborns at Highest Risk for Severe RSV
Researchers have created a new tool to identify newborns at the highest risk for severe RSV, enhancing the prioritization of immunoprophylaxis during shortages.
Tag: Nirsevimab RSV
All
Latest
All
Latest
Five RSV Articles for the Week
FDA panel favors approval for two RSV vaccines, 'Tripledemic' hits US households, and a monoclonal antibody may be ready for next season—here are five RSV stories you should check out this week.
